Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
outer membrane porin C
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| D18E | - | perturbs the transverse electrostatic field | E. coli | Cefotaxime | Reslit | Candidate |
| S271F | - | perturbs the transverse electrostatic field | E. coli | Cefotaxime | Reslit | Candidate |
| R124H | - | perturbs the transverse electrostatic field | E. coli | Cefotaxime |
| Candidate |
| D192G | - | - | - | Carbapenem | Reslit | Candidate |
| K173T | - | - | - | Carbapenem | Reslit | Candidate |
| N47D | - | - | - | Carbapenem | Reslit | Candidate |
| G138D | - | - | Escherichia coli | Carbapenem | Reslit | Candidate |
| R195L | - | outer membrane porin C OmpC | Escherichia coli | CarbapenemCeftazidime|Ceftriaxone|CefepimeCARBAPENEM | Reference Gene CatalogReslit | Confirmed |
| I104V | - | - | E. coli | Cefepime|Cephalothin | Reslit | Candidate |
| I6T | - | - | E. coli | Ceftazidime | Reslit | Candidate |
| I48S | - | - | Enterobacter cloacae | Cefoxitin|Cefotaxime|Cefepime|Ertapenem|Imipenem|Meropenem | Reslit | Candidate |
| A226D | - | increased susceptibility to β-lactam antibiotics | Escherichia coli | Ampicillin|Piperacillin | Reslit | Candidate |
| Q82Ter | - | outer membrane porin C OmpC | Escherichia coli | CARBAPENEM | Reference Gene Catalog | Established |
| Q171Ter | - | outer membrane porin C OmpC | Escherichia coli | CARBAPENEM | Reference Gene Catalog | Established |
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| ompC | Reslit | 10 | Ceftazidime, Cefepime +10 | Escherichia coli +7 | Europe|wastewater treatment plant, Japan, India | 2018, 2022, 2023, 2024, 2025 | PRJNA380388 | - |
| OM | Reslit | 1 | - | Achromobacter xylosoxidans BHW-15 | Bangladesh | 2019 | PZMK00000000.1 | - |
| porin_OmpC | Card Database | 1 | - | Escherichia coli | - | - | KY086517.1 | APB87301.1 |
Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides.
Antibiotic-resistant bacteria exhibit widespread collateral sensitivity to antimicrobial peptides, particularly PGLA. Mutations in marR, ompC, and sbmA contribute to this sensitivity by altering membrane properties and efflux mechanisms.
Adaptation of metal and antibiotic resistant traits in novel β-Proteobacterium Achromobacter xylosoxidans BHW-15.
The study identifies multiple antibiotic resistance genes in Achromobacter xylosoxidans BHW-15, including beta-lactamases, aminoglycoside-modifying enzymes, and efflux pumps, contributing to resistance against beta-lactams, aminoglycosides, and other antibiotics.
Mutations in SilS and CusS/OmpC represent different routes to achieve high level silver ion tolerance in Klebsiella pneumoniae.
The study identifies mutations in silS, cusS, and ompC as key mechanisms for achieving high-level silver ion tolerance in Klebsiella pneumoniae. These mutations lead to overexpression of the silCFBA or cusCFBA operons and disruption of the outer membrane porin OmpC, resulting in increased silver tolerance.
A genome-wide scan of wastewater E. coli for genes under positive selection: focusing on mechanisms of antibiotic resistance.
The study identifies ompC and hipA as genes under positive selection that correlate with antibiotic resistance. Non-synonymous mutations in these genes are associated with increased resistance to several antibiotics.
Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains.
The study identified that decreased expression of porin genes ompF, ompC, and phoE contributes to cefmetazole resistance in E. coli, particularly in ESBL-producing strains. The addition of relebactam suppressed resistance acquisition.
The evolution of antibiotic resistance in an incurable and ultimately fatal infection: A retrospective case study.
The study identifies multiple mutations in genes such as ampD, deoR, wecA, rcsC, ompC, ompD, and phoE that contribute to antibiotic resistance in Enterobacter hormaechei. These mutations include transposon insertions, deletions, and frameshift variants, leading to resistance against β-lactams, carbapenems, and other antibiotics.
Glyoxylate Shunt and Pyruvate-to-Acetoin Shift Are Specific Stress Responses Induced by Colistin and Ceragenin CSA-13 in Enterobacter hormaechei ST89.
The study identifies mgrB deletion and arnABCDEF, pagP overexpression as mechanisms for colistin resistance, and ompC and smvR disruption for CSA-13 resistance in Enterobacter hormaechei ST89.
Fosfomycin Uptake in Escherichia coli Is Mediated by the Outer-Membrane Porins OmpF, OmpC, and LamB.
The study identifies OmpF, OmpC, and LamB as critical outer-membrane porins involved in fosfomycin uptake in E. coli, with their deletion leading to increased resistance to fosfomycin.
Whole genome sequence-based molecular characterization of blood isolates of carbapenem-resistant Enterobacter cloacae complex from ICU patients in Kolkata, India, during 2017-2022: emergence of phylogenetically heterogeneous Enterobacter hormaechei subsp. xiangfangensis.
The study identified several carbapenemase and extended-spectrum beta-lactamase genes, including bla NDM-1, bla NDM-4, bla NDM-5, bla NDM-7, bla OXA-181, bla OXA-232, bla KPC-3, bla CTX-M-15, bla SFO-1, bla ACT, and bla CMH-3, in carbapenem-resistant Enterobacter cloacae complex isolates from Kolkata, India. Novel integrons (In180, In4874, In4887, and In4888) were also discovered.
Upregulation of outer membrane porin gene ompC contributed to enhancement of azithromycin susceptibility in multidrug-resistant Escherichia coli.
The study found that upregulation of the ompC gene enhanced azithromycin susceptibility in multidrug-resistant E. coli, while downregulation of the mph(A) gene reduced azithromycin resistance.
Tripartite Loops Reverse Antibiotic Resistance.
The study introduces tripartite loops consisting of three antibiotics to reverse antibiotic resistance in bacteria. By evolving resistance to a third drug, the study shows that resistance to the initial drugs can be reversed, leading to resensitization. The research highlights the role of specific genes and mutations in mediating resistance and resensitization, including genes involved in electron transport, efflux regulation, and nutrient transport.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research